How are WVE long put max profit and max loss calculated?

Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the WVE long put priced from the end-of-day chain at a 30-day expiry (ATM IV 102.60%), the computed maximum profit is $586.50 per contract and the computed maximum loss is -$112.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a WVE long put?

The breakeven for the WVE long put priced on this page is roughly $5.88 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current WVE market-implied 1-standard-deviation expected move is approximately 29.41%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current WVE implied volatility affect this long put?

WVE ATM IV is at 102.60% with IV rank near 30.64%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

WVE Long Put Strategy

WVE (Wave Life Sciences Ltd.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional proteins, or modulate protein expression. The company also develops WVE-004, a C9orf72 molecule for the treatment of amyotrophic lateral sclerosis and frontotemporal dementia; WVE-003, a mutant huntingtin SNP3 molecule for the treatment of Huntington's disease; WVE-N531, an Exon 53 molecule for the treatment of Duchenne muscular dystrophy; and ATXN3, a discovery stage program for the treatment of spinocerebellar ataxia 3, as well as multiple preclinical programs for CNS disorders. In addition, it focuses on developing GalNAc-conjugated AIMers to treat hepatic indications comprising Alpha-1 antitrypsin deficiency (AATD); and two preclinical programs, such as Usher syndrome type 2A (USH2A) and retinitis pigmentosa due to a P23H mutation in the RHO gene (RhoP23H) for the treatment of retinal diseases. It has collaboration agreements with Pfizer Inc., Takeda Pharmaceutical Company Limited, University of Oxford, University of Massachusetts, Western Washington University, Grenoble Institute of Neurosciences, IRBM S.p.A, University of Louisville, and University College London. The company was incorporated in 2012 and is based in Singapore.

WVE (Wave Life Sciences Ltd.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $1.34B, a beta of -1.32 versus the broader market, a 52-week range of 5.02-21.73, average daily share volume of 4.5M, a public-listing history dating back to 2015, approximately 287 full-time employees. These structural characteristics shape how WVE stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of -1.32 indicates WVE has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.

What is a long put on WVE?

A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.

Current WVE snapshot

As of May 15, 2026, spot at $6.75, ATM IV 102.60%, IV rank 30.64%, expected move 29.41%. The long put on WVE below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 63-day expiry.

Why this long put structure on WVE specifically: WVE IV at 102.60% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 29.41% (roughly $1.99 on the underlying). The 63-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated WVE expiries trade a higher absolute premium for lower per-day decay. Position sizing on WVE should anchor to the underlying notional of $6.75 per share and to the trader's directional view on WVE stock.

WVE long put setup

The WVE long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With WVE near $6.75, the first option leg uses a $7.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed WVE chain at a 63-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 WVE shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Put	$7.00	$1.13

WVE long put risk and reward

Net Premium / Debit: -$112.50
Max Profit (per contract): $586.50
Max Loss (per contract): -$112.50
Breakeven(s): $5.88
Risk / Reward Ratio: 5.213

Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.

WVE long put payoff curve

Modeled P&L at expiration across a range of underlying prices for the long put on WVE. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-99.9%	+$586.50
$1.50	-77.8%	+$437.36
$2.99	-55.7%	+$288.23
$4.48	-33.6%	+$139.09
$5.98	-11.5%	-$10.04
$7.47	+10.6%	-$112.50
$8.96	+32.7%	-$112.50
$10.45	+54.8%	-$112.50
$11.94	+76.9%	-$112.50
$13.43	+99.0%	-$112.50

When traders use long put on WVE

Long puts on WVE hedge an existing long WVE stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying WVE exposure being hedged.

WVE thesis for this long put

The market-implied 1-standard-deviation range for WVE extends from approximately $4.76 on the downside to $8.74 on the upside. A WVE long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long WVE position with one put per 100 shares held. Current WVE IV rank near 30.64% is mid-range against its 1-year distribution, so the IV signal is neutral; the long put thesis on WVE should anchor more to the directional view and the expected-move geometry. As a Healthcare name, WVE options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to WVE-specific events.

WVE long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. WVE positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move WVE alongside the broader basket even when WVE-specific fundamentals are unchanged. Long-premium structures like a long put on WVE are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current WVE chain quotes before placing a trade.

Frequently asked questions

What is a long put on WVE?: A long put on WVE is the long put strategy applied to WVE (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With WVE stock trading near $6.75, the strikes shown on this page are snapped to the nearest listed WVE chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are WVE long put max profit and max loss calculated?: Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the WVE long put priced from the end-of-day chain at a 30-day expiry (ATM IV 102.60%), the computed maximum profit is $586.50 per contract and the computed maximum loss is -$112.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a WVE long put?: The breakeven for the WVE long put priced on this page is roughly $5.88 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current WVE market-implied 1-standard-deviation expected move is approximately 29.41%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long put on WVE?: Long puts on WVE hedge an existing long WVE stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying WVE exposure being hedged.
How does current WVE implied volatility affect this long put?: WVE ATM IV is at 102.60% with IV rank near 30.64%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.